Acadia Healthcare Company Inc (ACHC) concluded trading on Thursday at a closing price of $24.22, with 5.06 million shares of worth about $122.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -42.78% during that period and on May 08, 2025 the price saw a gain of about 0.25%. Currently the company’s common shares owned by public are about 91.78M shares, out of which, 89.71M shares are available for trading.
Stock saw a price change of 6.32% in past 5 days and over the past one month there was a price change of -10.69%. Year-to-date (YTD), ACHC shares are showing a performance of -38.92% which decreased to -64.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $20.36 but also hit the highest price of $82.40 during that period. The average intraday trading volume for Acadia Healthcare Company Inc shares is 2.47 million. The stock is currently trading 3.34% above its 20-day simple moving average (SMA20), while that difference is down -10.59% for SMA50 and it goes to -48.83% lower than SMA200.
Acadia Healthcare Company Inc (NASDAQ: ACHC) currently have 91.78M outstanding shares and institutions hold larger chunk of about 106.11% of that.
The stock has a current market capitalization of $2.23B and its 3Y-monthly beta is at 0.97. PE ratio of stock for trailing 12 months is 8.72, while it has posted earnings per share of $2.78 in the same period. It has Quick Ratio of 0.99 while making debt-to-equity ratio of 0.68. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACHC, volatility over the week remained 4.20% while standing at 6.20% over the month.
Stock’s fiscal year EPS is expected to drop by -19.53% while it is estimated to increase by 13.39% in next year. EPS is likely to shrink at an annualized rate of -0.99% for next 5-years, compared to annual growth of 17.49% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barclays on February 28, 2025 offering an Equal weight rating for the stock and assigned a target price range of between $43 and $35 to it. Coverage by KeyBanc Capital Markets stated Acadia Healthcare Company Inc (ACHC) stock as an Overweight in their note to investors on January 07, 2025, suggesting a price target of $70 for the stock. Stock get a Hold rating from Deutsche Bank on April 25, 2024.
